155 related articles for article (PubMed ID: 10438517)
1. Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein.
Zanusso G; Petersen RB; Jin T; Jing Y; Kanoush R; Ferrari S; Gambetti P; Singh N
J Biol Chem; 1999 Aug; 274(33):23396-404. PubMed ID: 10438517
[TBL] [Abstract][Full Text] [Related]
2. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
Mishra RS; Bose S; Gu Y; Li R; Singh N
J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
[TBL] [Abstract][Full Text] [Related]
3. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation.
Drisaldi B; Stewart RS; Adles C; Stewart LR; Quaglio E; Biasini E; Fioriti L; Chiesa R; Harris DA
J Biol Chem; 2003 Jun; 278(24):21732-43. PubMed ID: 12663673
[TBL] [Abstract][Full Text] [Related]
4. Prion protein with Y145STOP mutation induces mitochondria-mediated apoptosis and PrP-containing deposits in vitro.
Hachiya NS; Watanabe K; Kawabata MY; Jozuka A; Kozuka Y; Sakasegawa Y; Kaneko K
Biochem Biophys Res Commun; 2005 Feb; 327(3):894-9. PubMed ID: 15649429
[TBL] [Abstract][Full Text] [Related]
5. The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome.
Jin T; Gu Y; Zanusso G; Sy M; Kumar A; Cohen M; Gambetti P; Singh N
J Biol Chem; 2000 Dec; 275(49):38699-704. PubMed ID: 10970892
[TBL] [Abstract][Full Text] [Related]
6. Proteinase-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred).
Piccardo P; Seiler C; Dlouhy SR; Young K; Farlow MR; Prelli F; Frangione B; Bugiani O; Tagliavini F; Ghetti B
J Neuropathol Exp Neurol; 1996 Nov; 55(11):1157-63. PubMed ID: 8939199
[TBL] [Abstract][Full Text] [Related]
7. A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.
Stewart RS; Drisaldi B; Harris DA
Mol Biol Cell; 2001 Apr; 12(4):881-9. PubMed ID: 11294893
[TBL] [Abstract][Full Text] [Related]
8. Selective processing and metabolism of disease-causing mutant prion proteins.
Ashok A; Hegde RS
PLoS Pathog; 2009 Jun; 5(6):e1000479. PubMed ID: 19543376
[TBL] [Abstract][Full Text] [Related]
9. Proteasomal degradation of tau protein.
David DC; Layfield R; Serpell L; Narain Y; Goedert M; Spillantini MG
J Neurochem; 2002 Oct; 83(1):176-85. PubMed ID: 12358741
[TBL] [Abstract][Full Text] [Related]
10. A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation.
Tunnell E; Wollman R; Mallik S; Cortes CJ; Dearmond SJ; Mastrianni JA
Neurology; 2008 Oct; 71(18):1431-8. PubMed ID: 18955686
[TBL] [Abstract][Full Text] [Related]
11. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V.
Tagliavini F; Lievens PM; Tranchant C; Warter JM; Mohr M; Giaccone G; Perini F; Rossi G; Salmona M; Piccardo P; Ghetti B; Beavis RC; Bugiani O; Frangione B; Prelli F
J Biol Chem; 2001 Feb; 276(8):6009-15. PubMed ID: 11087738
[TBL] [Abstract][Full Text] [Related]
12. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques.
Kitamoto T; Iizuka R; Tateishi J
Biochem Biophys Res Commun; 1993 Apr; 192(2):525-31. PubMed ID: 8097911
[TBL] [Abstract][Full Text] [Related]
13. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.
Yedidia Y; Horonchik L; Tzaban S; Yanai A; Taraboulos A
EMBO J; 2001 Oct; 20(19):5383-91. PubMed ID: 11574470
[TBL] [Abstract][Full Text] [Related]
14. Y145Stop is sufficient to induce de novo generation prions using protein misfolding cyclic amplification.
Abdallah A; Wang P; Richt JA; Sreevatsan S
Prion; 2012; 6(1):81-8. PubMed ID: 22453182
[TBL] [Abstract][Full Text] [Related]
15. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.
Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851
[TBL] [Abstract][Full Text] [Related]
16. Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems.
Raeber AJ; Borchelt DR; Scott M; Prusiner SB
J Virol; 1992 Oct; 66(10):6155-63. PubMed ID: 1356161
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility.
Tenzer S; Stoltze L; Schönfisch B; Dengjel J; Müller M; Stevanović S; Rammensee HG; Schild H
J Immunol; 2004 Jan; 172(2):1083-91. PubMed ID: 14707082
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations.
Fioriti L; Dossena S; Stewart LR; Stewart RS; Harris DA; Forloni G; Chiesa R
J Biol Chem; 2005 Mar; 280(12):11320-8. PubMed ID: 15632159
[TBL] [Abstract][Full Text] [Related]
19. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells.
Dron M; Dandoy-Dron F; Farooq Salamat MK; Laude H
J Gen Virol; 2009 Aug; 90(Pt 8):2050-2060. PubMed ID: 19339478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
